Understanding tumour growth variability in patient-derived breast cancer xenograft models identifies early responders and biomarkers of resistance to PARP inhibition
M O'Connor, D Voulgarelis, J Forment… - 2024 - researchsquare.com
Understanding mechanisms of resistance to PARP inhibitors (PARPi) represents a clinically
relevant goal that is addressed in this study using a novel methodology. A framework has …
relevant goal that is addressed in this study using a novel methodology. A framework has …